Inactivation of pathogens during aerobic and anaerobic treatments at low temperatures.
Singh
L
L
Defence R&D Establishment, Gwalior, India.
Ram
M S
MS
Alam
S I
SI
Maurya
M S
MS
D000085:Acetates / Q000494:pharmacology; D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D001173:Arthrobacter / Q000254:growth & development / Q000378:metabolism*; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development*; D005618:Fresh Water; D006801:Humans; D011422:Propionates / Q000494:pharmacology; D011817:Rabbits; D012485:Salmonella typhi / Q000187:drug effects / Q000254:growth & development*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development*; D013440:Sulfides / Q000494:pharmacology; D013696:Temperature; D014631:Valerates / Q000494:pharmacology; D014865:Waste Disposal, Fluid / Q000379:methods; D014871:Water Microbiology
D000085:Acetates; D002087:Butyrates; D011422:Propionates; D013440:Sulfides; D014631:Valerates; D020148:Butyric Acid; C029658:propionic acid; C033479:sodium sulfide